LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹38 Cr | ₹33 Cr | ₹99 Cr | ₹50 Cr | ₹66 Cr |
What is the latest Total Current Liabilities ratio of LYKA LABS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹38 Cr |
Mar2023 | ₹33 Cr |
Mar2022 | ₹99 Cr |
Mar2021 | ₹50 Cr |
Mar2020 | ₹66 Cr |
How is Total Current Liabilities of LYKA LABS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹38 Cr | 15.47 | |
Mar2023 | ₹33 Cr | -67.19 | |
Mar2022 | ₹99 Cr | 99.18 | |
Mar2021 | ₹50 Cr | -24.79 | |
Mar2020 | ₹66 Cr | - |
Compare Total Current Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹376.6 Cr | 3.1% | 0.7% | -2.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 3.1% |
0.7% |
-2.8% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses